• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

头颈部癌患者的一般健康措施与长期生存

General health measures and long-term survival in patients with head and neck cancer.

作者信息

Grignon Laurent M, Jameson Mark J, Karnell Lucy Hynds, Christensen Alan J, Funk Gerry F

机构信息

Department of Otolaryngology-Head and Neck Surgery, Roy J. and Lucille A. Carver College of Medicine, The University of Iowa, Iowa City, IA 52242-1093, USA.

出版信息

Arch Otolaryngol Head Neck Surg. 2007 May;133(5):471-6. doi: 10.1001/archotol.133.5.471.

DOI:10.1001/archotol.133.5.471
PMID:17520761
Abstract

OBJECTIVE

To determine whether a self-reported, subjective general health assessment tool can provide prognostic information about survival in patients with head and neck cancer.

DESIGN

Prospective observational cohort study.

SETTING

Tertiary care center.

PATIENTS

Five hundred seventy-one patients with squamous cell carcinoma of the upper aerodigestive tract who were enrolled in the institution's longitudinal Outcomes Assessment Project between January 1, 1995, and November 30, 2004.

MAIN OUTCOME MEASURES

Actuarial 5-year observed and disease-specific survival.

RESULTS

The physical component summary obtained from the SF-36 (Medical Outcomes Study 36-Item Short-Form Health Survey) was significantly associated with ACE-27 (Adult Comorbidity Evaluation-27) comorbidity ratings. The mental component summary was not associated with ACE-27 scores or survival. Although the comorbidity rating was an independent predictor of observed survival (P = .002) only, the physical component summary was independently predictive of both observed (P<.001) and disease-specific (P = .001) survival. These associations continued to be independently significant when site and stage were included in the analysis (P = .003, P<.001, and P = .004, respectively).

CONCLUSION

The physical component summary generated by the SF-36, a self-reported, subjective measure of general physical health, is predictive of both observed and disease-specific survival.

摘要

目的

确定一种自我报告的主观总体健康评估工具能否提供有关头颈癌患者生存的预后信息。

设计

前瞻性观察性队列研究。

地点

三级医疗中心。

患者

1995年1月1日至2004年11月30日期间纳入该机构纵向结局评估项目的571例上消化道鳞状细胞癌患者。

主要结局指标

精算5年观察生存率和疾病特异性生存率。

结果

从SF-36(医学结局研究36项简短健康调查)获得的身体成分总结与ACE-27(成人合并症评估-27)合并症评级显著相关。心理成分总结与ACE-27评分或生存率无关。虽然合并症评级仅是观察生存率的独立预测因素(P = .002),但身体成分总结是观察生存率(P<.001)和疾病特异性生存率(P = .001)的独立预测因素。当分析中纳入部位和分期时,这些关联仍然具有独立显著性(分别为P = .003、P<.001和P = .004)。

结论

SF-36生成的身体成分总结,一种自我报告的主观总体身体健康测量方法,可预测观察生存率和疾病特异性生存率。

相似文献

1
General health measures and long-term survival in patients with head and neck cancer.头颈部癌患者的一般健康措施与长期生存
Arch Otolaryngol Head Neck Surg. 2007 May;133(5):471-6. doi: 10.1001/archotol.133.5.471.
2
First-year trends in self-reported general health predict survival in patients with head and neck cancer.自我报告的总体健康状况的第一年趋势可预测头颈癌患者的生存率。
Arch Otolaryngol Head Neck Surg. 2008 Sep;134(9):958-64. doi: 10.1001/archotol.134.9.958.
3
Health-related quality of life scores in long-term head and neck cancer survivors predict subsequent survival: a prospective cohort study.长期头颈部癌症幸存者的健康相关生活质量评分可预测后续生存:一项前瞻性队列研究。
Clin Otolaryngol. 2011 Aug;36(4):361-8. doi: 10.1111/j.1749-4486.2011.02342.x.
4
Comorbidity is a prognostic factor in elderly patients with head and neck cancer.合并症是老年头颈癌患者的一个预后因素。
Ann Surg Oncol. 2007 Apr;14(4):1449-57. doi: 10.1245/s10434-006-9296-1. Epub 2007 Jan 18.
5
Effect of comorbidity on quality of life and treatment selection in patients with squamous cell carcinoma of the head and neck.合并症对头颈部鳞状细胞癌患者生活质量及治疗选择的影响
Laryngoscope. 2005 Aug;115(8):1371-5. doi: 10.1097/01.mlg.0000167983.32017.64.
6
Cyclin D1 and FADD as biomarkers in head and neck squamous cell carcinoma.细胞周期蛋白 D1 和 FADD 作为头颈部鳞状细胞癌的生物标志物。
Otolaryngol Head Neck Surg. 2012 Jun;146(6):923-31. doi: 10.1177/0194599811435052. Epub 2012 Feb 8.
7
Prognostic factors for survival after salvage reirradiation of head and neck cancer.头颈部癌挽救性再放疗后生存的预后因素。
J Clin Oncol. 2009 Apr 20;27(12):1983-91. doi: 10.1200/JCO.2008.20.0691. Epub 2009 Mar 16.
8
Long-term health-related quality of life in survivors of head and neck cancer.头颈癌幸存者与健康相关的长期生活质量
Arch Otolaryngol Head Neck Surg. 2012 Feb;138(2):123-33. doi: 10.1001/archoto.2011.234. Epub 2012 Jan 16.
9
Lymph node metastases from cutaneous squamous cell carcinoma of the head and neck.头颈部皮肤鳞状细胞癌的淋巴结转移
Laryngoscope. 2005 Sep;115(9):1561-7. doi: 10.1097/01.mlg.0000173202.56739.9f.
10
The role of pain in head and neck cancer recurrence and survivorship.疼痛在头颈癌复发和生存中的作用。
Arch Otolaryngol Head Neck Surg. 2009 Aug;135(8):789-94. doi: 10.1001/archoto.2009.107.

引用本文的文献

1
Predictors of survival among head and neck cancer patients after radiotherapy based on health-related quality of life indices and symptoms-specific outcomes: a systematic review.基于健康相关生活质量指标和症状特异性结果对头颈部癌症患者放疗后生存的预测因素:一项系统综述
Qual Life Res. 2025 Apr 11. doi: 10.1007/s11136-025-03933-y.
2
Health-Related Quality of Life Scores and Values as Predictors of Mortality: A Scoping Review.健康相关生活质量评分和价值观作为死亡率预测因素的研究综述。
J Gen Intern Med. 2023 Nov;38(15):3389-3405. doi: 10.1007/s11606-023-08380-4. Epub 2023 Aug 31.
3
Implementing a cognitive behavioral intervention for patients with head and neck cancer.
实施针对头颈部癌症患者的认知行为干预。
Support Care Cancer. 2023 Jul 19;31(8):476. doi: 10.1007/s00520-023-07948-4.
4
Predictive value of health-related quality of life on radiotherapy-related toxicities in patients with head and neck cancer.健康相关生活质量对头颈部癌症患者放射治疗相关毒性的预测价值。
Support Care Cancer. 2023 Apr 14;31(5):268. doi: 10.1007/s00520-023-07736-0.
5
Quality of life score as a prognosticator for pharyngeal cancer patients treated with radiotherapy.生活质量评分作为预测接受放疗的咽癌患者预后的指标。
Sci Rep. 2022 Feb 11;12(1):2387. doi: 10.1038/s41598-022-06441-y.
6
Oral and general health-related quality of life in oral squamous cell carcinoma patients- comparative analysis of different treatment regims.口腔鳞状细胞癌患者的口腔及总体健康相关生活质量——不同治疗方案的比较分析
J Oral Biol Craniofac Res. 2021 Apr-Jun;11(2):125-131. doi: 10.1016/j.jobcr.2021.01.004. Epub 2021 Jan 6.
7
Health-related quality of life and overall survival: a prospective study in patients with head and neck cancer treated with radiotherapy.健康相关生活质量和总生存:放疗治疗的头颈部癌症患者的前瞻性研究。
Qual Life Res. 2021 Apr;30(4):1145-1153. doi: 10.1007/s11136-020-02716-x. Epub 2020 Dec 8.
8
EORTC Quality of Life Questionnaire Head and Neck (H&N)-35 scores from H&N squamous cell carcinoma patients obtained at diagnosis and at 6, 9 and 12 months following diagnosis predict 10-year overall survival.EORTC 头颈部癌症生存质量问卷(H&N-35)评分在头颈部鳞癌患者诊断时及诊断后 6、9 和 12 个月获得,可预测 10 年总生存率。
Eur Arch Otorhinolaryngol. 2019 Dec;276(12):3495-3505. doi: 10.1007/s00405-019-05630-2. Epub 2019 Sep 16.
9
Single-Fraction Stereotactic vs Conventional Multifraction Radiotherapy for Pain Relief in Patients With Predominantly Nonspine Bone Metastases: A Randomized Phase 2 Trial.单剂量立体定向与常规多分割放射治疗对以非脊柱骨转移为主的患者疼痛缓解的比较:一项随机 2 期试验。
JAMA Oncol. 2019 Jun 1;5(6):872-878. doi: 10.1001/jamaoncol.2019.0192.
10
General health-related quality of life scores from head and neck squamous cell carcinoma patients obtained throughout the first year following diagnosis predicted up to 10-year overall survival.头颈部鳞状细胞癌患者在诊断后的第一年中获得的一般健康相关生活质量评分可预测长达10年的总生存期。
Eur Arch Otorhinolaryngol. 2018 Jan;275(1):207-217. doi: 10.1007/s00405-017-4800-8. Epub 2017 Nov 20.